Loading…
EMBC
Embecta Corp.
NASDAQ· Healthcare· Medical Instruments & Supplies· CUSIP 29082K105
$6.86+2.69%Price as of Oct 23, 00:52 UTC · updated once a day, after the close
At a glance
Embecta Corp. (EMBC) is listed on NASDAQ and classified in Medical Instruments & Supplies, part of the Healthcare sector. It is headquartered in Parsippany, United States and has 1,850 employees. The company is worth $388.68M and trades at 4.5x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was $1.08B in fiscal 2025, down 3.8% from the year before. Net income was $95.4M. The share price is 54.0% below its 52-week high of $14.91. It pays a dividend yielding 4.66%. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $3.17M. In that quarter, 1 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $388.68M
- P/E
- 4.5x
- Forward P/E
- 3.9x
- P/B
- —
- Dividend yield
- 4.66%
- Payout
- 21.19%
- EPS
- $1.51
- ROE
- —
- Profit margin
- 8.59%
- Revenue growth
- -8.10%
- Beta
- 0.83
- 52-week high
- $14.91
- 52-week low
- $2.77
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -81.2% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $11.88 | $20.65 | $18.93 | $25.29 | |
| P/E | 11.4x | 7.3x | 15.4x | 15.5x | 6.5x |
| P/S | 1.0x | 0.6x | 1.1x | 1.0x | 1.3x |
| EPS | $1.62 | $1.34 | $1.22 | $3.89 | |
| Dividend yield | 3.04% | 5.05% | 2.91% | 3.17% |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
$7.04
Earnings growing 0.0% a year plus a 4.7% dividend yield. Growth capped at 25%.
Earnings
$36.67
Median P/E of 24.3 among peers in the sector.
Earnings
$17.17
Median P/E of 11.4 across this company’s own years on record.
Cash flow
$31.06
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
$47.93
Sector median of 14.1x operating profit, less net debt. Banks have no EBITDA.
Dividends
$7.36
Dividend growing 0.0% a year against a 8.2% required return, from the stock’s beta.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CAPRCapricor Therapeutics Inc | $6.71 | — | 1.6x | 0.00% | -73.70% | $390.11M |
| CCCCC4 Therapeutics, Inc. | $3.18 | — | 1.6x | 0.00% | -48.14% | $391.22M |
| TRXBTRex Bio, Inc. | $14.01 | — | — | 0.00% | — | $384.51M |
| AUNAAUNA S.a | $5.32 |
About the company
- 1,850
- Parsippany, United States